MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Waters Corporation ROE Ratio 2011-2026 | WAT
Annual ROE Ratio Waters Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.09 | 34.88 | 55.83 | 140.29 | 188.5 | 224.68 | -273.81 | 37.89 | 0.91 | 22.65 | 22.78 | 22.78 | 25.52 | 31.45 | 35.3 | - | 38.08 | 48.79 | 45.74 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 224.68 | -273.81 | 40.41 |
Quarterly ROE Ratio Waters Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.92 | 29.46 | 33.18 | 34.5 | 28.32 | 43.18 | 52.62 | 66.01 | 57.87 | 182.65 | 210.42 | 249.73 | 226.24 | 387.68 | 262.9 | 325.26 | 346.76 | 381.97 | 351.17 | 364.84 | 323.77 | 136.95 | -174.71 | -367.9 | -441.36 | -336.77 | -129.66 | 4.57 | 62.11 | 34.48 | 25.13 | 18.68 | 16.26 | 39.65 | 28.35 | 23.29 | 22.65 | 22.43 | 22.65 | 22.21 | 22.79 | 23.43 | 23.77 | 23.74 | 22.78 | 22.83 | 22.4 | 22.37 | 25.52 | 26.78 | 30.95 | 35.45 | 28.58 | 28.58 | 28.58 | 28.58 | 28.58 | 28.58 | 28.58 | 28.58 | 28.58 | 28.58 | 9.29 | 9.73 | 9.57 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 387.68 | -441.36 | 55.75 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Fulgent Genetics
FLGT
|
-5.44 | $ 19.5 | 7.5 % | $ 600 M | USA |
 |
Celcuity
CELC
|
-176.06 | $ 92.47 | 3.96 % | $ 4.32 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 5.76 | 11.41 % | $ 7.66 M | USA |
 |
Castle Biosciences
CSTL
|
-5.13 | $ 21.6 | 5.93 % | $ 626 M | USA |
 |
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
419.21 | $ 133.06 | 4.75 % | $ 16.7 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
ICON Public Limited Company
ICLR
|
2.49 | $ 152.8 | 6.18 % | $ 12 B |  Irlanda |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 23.12 | 3.63 % | $ 1.23 B | USA |
 |
Illumina
ILMN
|
31.22 | $ 168.06 | -1.68 % | $ 26 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
-3677.41 | - | - | $ 24.3 B |  Schweiz |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | - | - | $ 6.94 B | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 11.31 | 11.54 % | $ 1.45 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 185.79 | 3.29 % | $ 9.21 B | USA |
 |
Natera
NTRA
|
-12.16 | $ 222.1 | 4.84 % | $ 30.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 458.69 | 1.75 % | $ 13.2 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 19.75 | 3.73 % | $ 442 M | USA |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 4.69 | 6.59 % | $ 434 M | USA |
 |
Personalis
PSNL
|
-31.12 | $ 12.1 | 12.24 % | $ 1.08 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 25.99 | 2.52 % | $ 24.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 7.01 | 4.32 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-121.14 | - | - | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 260.97 | 0.79 % | $ 21.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | - | - | $ 4.42 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 482.03 | 1.7 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
88.73 | $ 0.68 | -2.4 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.12 | 3.52 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 196.12 | 1.27 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |